#shantanu kumar singh taj pharma

[thoughtfulenthusiastgoatee-blog]

Taj Pharma Launches VENOSTOR(TM) (Diosmin/Hesperidin Tablets) Unique Natural Formula

MUMBAI, November 4, 2016 /PRNewswire/ —

Taj Pharma’s VENOSTOR™ (Diosmin/Hesperidin, 30 Tablets) Improves Vascular Tone, Supports Lymphatic Drainage of the Legs and Strengthens Vascular Structures

Taj Pharma launches VENOSTOR™ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health.

    (Photo: http://photos.prnewswire.com/prnh/20161104/436235 )

VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin.

Treatment of venous disease

Chronic venous disease (CVD)

Hemorrhoidal disease (HD)

Dietary supplement

VENOSTOR 500 mg and 1000 mg (Micronized purified flavonoid fraction) Tablets:- This medication is a phlebotrope: it increases the tone of veins and resistance of small blood vessels. It is shown in: • The treatment of disorders of the venous circulation such as heavy legs, pain, restlessness (irresistible urge to move the legs), night cramps, edema, trophic disorders (lesions skin due to poor blood supply) • The treatment of acute hemorrhoidal disease crisis, it is proposed in the treatment of hemorrhoidal disease background (pain, bleeding, scratch)

Diosmin/Hesperidin

Diosmin – flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin – flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin – flavonoid 500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance.

More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/

Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a global scale.

Other intended markets for this product are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela.

About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com

[asiainfomed-blog]

Taj Pharma india Taj Pharma products Taj Pharma wiki Taj Pharma chennai Taj Pharma company Taj Pharma subsidiaries Taj Pharma headquarters Taj Pharma locations Taj Pharma mumbai jobs Taj Pharma india jobs Taj Pharma pharmaceuticals india pvt ltd Taj Pharma chennai Taj Pharma ltd. mumbai, maharashtra Taj Pharma hyderabad Taj Pharma pune Taj Pharma products in india popular Taj Pharma products Taj Pharma products search results Taj Pharma product list pdf Taj Pharma products viagra Taj Pharma products mentioned on wikipedia Taj Pharma otc products in india what is Taj Pharma abhishek singh house abhishek singh daughter abhishek singh caste abhishek singh biography abhishek singh wife abhishek singh son abhishek singh cars abhishek singh company abhishek singh wife taj pharma product list Shantanu Singh Taj Pharma priyanka singh taj pharma priyanka singh taj pharmaceuticals turnover, abhishek taj pharma abhishek kumar singh taj pharma

[thoughtfulenthusiastgoatee-blog]

Taj Pharma Launches VENOSTOR™ (Diosmin/Hesperidin Tablets) Unique Natural FormulaFriday, November 4, 2016

MUMBAI, November 4, 2016 /PRNewswire/ --

Taj Pharma's VENOSTOR™ (Diosmin/Hesperidin, 30 Tablets) Improves Vascular Tone, Supports Lymphatic Drainage of the Legs and Strengthens Vascular Structures

Taj Pharma launches VENOSTOR™ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health.

    (Photo: http://photos.prnewswire.com/prnh/20161104/436235 )

VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin.

Treatment of venous disease

Chronic venous disease (CVD)

Hemorrhoidal disease (HD)

Dietary supplement

VENOSTOR 500 mg and 1000 mg (Micronized purified flavonoid fraction) Tablets:- This medication is a phlebotrope: it increases the tone of veins and resistance of small blood vessels. It is shown in: • The treatment of disorders of the venous circulation such as heavy legs, pain, restlessness (irresistible urge to move the legs), night cramps, edema, trophic disorders (lesions skin due to poor blood supply) • The treatment of acute hemorrhoidal disease crisis, it is proposed in the treatment of hemorrhoidal disease background (pain, bleeding, scratch)  

Diosmin/Hesperidin

Diosmin - flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin - flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin - flavonoid 500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance.

More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/

Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a global scale.

Other intended markets for this product are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela.

About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com

Media Contact:  +91-22-26374592 Taj Pharmaceuticals Ltd.

[thoughtfulenthusiastgoatee-blog]

“STORY OF A BLIND GIRL. ”- SHORT STORY A STORY FROM ABHISHEK KUMAR SINGH,. CEO TAJ PHARMA INDIA (MUMBAI)

STORY OF A BLIND GIRL.

There was a blind girl who hated herself just because she was blind. She hated everyone, except her loving boyfriend. He was always there for her. She said that if she could only see the world, she would marry her boyfriend. One day, someone donated a pair of eyes to her and then she could see everything, including her boyfriend. Her boyfriend asked her, “now that you can see the world, will you marry me?” The girl was shocked when she saw that her boyfriend was blind too, and refused to marry him. Her boyfriend walked away in tears, and later wrote a letter to her saying:

“Just take care of my eyes dear.”

This is how human brain changes wen the status changed. Only few remember wat life was before, and who’s always been there even in the most painful situations.

A STORY FROM

ABHISHEK KUMAR SINGH,. CEO TAJ PHARMA INDIA (MUMBAI)

[thoughtfulenthusiastgoatee-blog]

Abhishek Kumar Singh (Taj Pharma) Ceo

Abhishek Kumar Singh (Taj Pharma) By: workspace.co.uk/ 12th Sept 2014

In December 2006, Abhishek Singh launched the first 90 generics in the pharma isolated market of Lebanon. In its first year these cost effective generics received more than 1 million users who could not afford branded medicines in their own county. This new avenue of choice was built entirely by Abhishek Singh, 21-year-old with no previous extensive work expertise in pharmaceuticals industry. According to CNBC, Singh learned everything he needed to know through practical experience at pharma manufacturing units, and proposed to develop 4,000 generics in the next decade as a core goal. One interesting bit of news that really got my attention this week was that of Abhishek Singh, the 21-year-old millionaire (yes, millionaire at 21!), who sold his New Generics to much in need countries such as Lebanon, Brazil, Senegal for millions! It’s quite an interesting story actually: Abhishek Singh started using the computer at 9, and began visiting his father pharma plants from 1999 when he was 11 – back when the concept of generic medicine was quite new in the market and India was known to only make copy products which are out of patent. Abhishek Singh’s first ‘success’ was with Tacrolimus Capsules, an immunosuppressive drug used mainly after allogeneic "organ transplant" to lower the risk of organ rejection. This generic launch was as quite popular – so much so that this was tendered by almost 28 countries in a span of 4 years till the new bio-similar sirolimus Capsule. Abhishek Singh was offered $300,000 from a Turkey based venture capital funding billionaire for Tacrolimus; to sell its technology with full rights. He refused this money, along with the feedback and criticism that selling such right of a bio-similar which was already not affordable in India; would further mean deprivation access to such life saving medicines. The Globe and Mail from Canada ran a cool story on the 21 year old’s rise in fame, as well as some unique advice offered to the young entrepreneur/ young millionaire. Worth a read! Abhishek Singh’s who is satisfied with his company's current global exposure; highlights that it's very easy get investment in pharma company; however, if greedy investors are allowed on the board of noble pharma companies; the greed always leads to drug price manipulation and then even though a company may become large scale, but essential purpose and motto of A.K.Singh from Taj Pharma may be defeated; human kind shall not make money from/at the cost essential life saving medicines and access to medicine shall be basic human right. Makes for a very interesting read!

[thoughtfulenthusiastgoatee-blog]

GREAT ATTITUDE Abhishek Kumar Singh - Taj Pharma

"GREAT ATTITUDE”

Once a Bird asked a BEE, After a continuous hard work, you prepare the honey.......... But a man steals the honey. Do you not feel sad?" Then the Bee replied, Never...... Because a man can only steal my honey, not the art of making honey.... A STORY FROM ABHISHEK KUMAR SINGH,. CEO TAJ PHARMA INDIA (MUMBAI)

[thoughtfulenthusiastgoatee-blog]

A POUND OF BUTTER - SHORT STORY - Copy Abhishek Kumar Singh - Taj Pharma

A POUND OF BUTTER - SHORT STORY

There was a farmer who sold a pound of butter to the baker. One day the baker decided to weigh the butter to see if he was getting a pound and he found that he was not. This angered him and he took the farmer to court. The judge asked the farmer if he was using any measure. The farmer replied, amour Honor, I am primitive. I don't have a proper measure, but I do have a scale." The judge asked, "Then how do you weigh the butter?" The farmer replied "Your Honor, long before the baker started buying butter from me, I have been buying a pound loaf of bread from him. Every day when the baker brings the bread, I put it on the scale and give him the same weight in butter. If anyone is to be blamed, it is the baker." What is the moral of the story? We get back in life what we give to others. Whenever you take an action, ask yourself this question: Am I giving fair value for the wages or money I hope to make? Honesty and dishonesty become a habit. Some people practice dishonesty and can lie with a straight face. Others lie so much that they don't even know what the truth is anymore. But who are they deceiving? Themselves

A STORY FROM ABHISHEK KUMAR SINGH,. CEO TAJ PHARMA INDIA (MUMBAI)

[thoughtfulenthusiastgoatee-blog]

Taj Pharma Launches VENOSTOR(TM) (Diosmin/Hesperidin Tablets) Unique Natural Formula

By: PR Newswire Association LLC. - 04 Nov 2016

Back to overview list

MUMBAI, November 4, 2016 /PRNewswire/ --

Taj Pharma's VENOSTOR™ (Diosmin/Hesperidin, 30 Tablets) Improves Vascular Tone, Supports Lymphatic Drainage of the Legs and Strengthens Vascular Structures

Taj Pharma launches VENOSTOR™ (Diosmin/Hesperidin Tablets). This unique natural formula combines two powerful antioxidant flavonoids to promote healthy blood flow in the legs and throughout the body. VENOSTOR (Diosmin/Hesperidin) is a unique natural formula that combines two powerful antioxidant flavonoids to support healthy blood flow in the legs and throughout the body. Derived from the sweet orange (Citrus aurantium skin), VENOSTOR (Diosmin/Hesperidin) supports circulatory health.

    (Photo: http://photos.prnewswire.com/prnh/20161104/436235 )

VENOSTOR 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin.

Treatment of venous disease

Chronic venous disease (CVD)

Hemorrhoidal disease (HD)

Dietary supplement

VENOSTOR 500 mg and 1000 mg (Micronized purified flavonoid fraction) Tablets:- This medication is a phlebotrope: it increases the tone of veins and resistance of small blood vessels. It is shown in: • The treatment of disorders of the venous circulation such as heavy legs, pain, restlessness (irresistible urge to move the legs), night cramps, edema, trophic disorders (lesions skin due to poor blood supply) • The treatment of acute hemorrhoidal disease crisis, it is proposed in the treatment of hemorrhoidal disease background (pain, bleeding, scratch)

Diosmin/Hesperidin

Diosmin - flavonoid 500 mg (Generic) is an oral phlebotropic drug indicated in the treatment of venous disease, i.e., Chronic Venous Disease (CVD) and Hemorrhoidal Disease (HD). Diosmin - flavonoid 500 mg is a unique micronized purified flavonoid fraction (MPFF) containing 90% diosmin (450 mg) and 10% flavonoids (50 mg) expressed as Hesperidin. The unique active substance of DAFLON 500 mg is composed of diosmin and active concomitant flavonoid substances: hesperidin, isorhoifolin, linarin and diosmetin. Hesperidin is extracted from a species of Rutaceae aurantieae, a type of immature small orange harvested and dried in Spain, North Africa, and China. Diosmin, a member of the flavonoid family, is synthesized starting from this raw material. Diosmin - flavonoid 500 mg differs from ordinary diosmin by its unique composition in flavonoids and the unique micronization of its active substance.

More details: http://tajpharmaindia.com/product/venostor-diosmin-hesperidin/

Taj Pharma has launched VENOSTOR Tablets in Indian market and also plans to launch the same for export markets. Taj Pharma also received approval for its manufacturing permission for generic versions of Diosmin/Hesperidin tablets, 500 mg, 1000 mg, and intends to commercialize this on a global scale.

Other intended markets for this product are Russia, CIS, Latin America territories where the Spanish or Portuguese language packs will be launched for ease in Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Falkland Islands, French Guiana, Guatemala, Guyana, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay and Venezuela.

About Taj Pharma: Taj Pharma is one of the leading generic pharmaceutical companies in India. We hold top positions in different established markets and gradually building a strong presence in many emerging generics markets. Today, we market more than 100 branded and 500+ generics compositions to consumers in more than 28 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products; more at http://www.tajpharma.com

[thoughtfulenthusiastgoatee-blog]

“Controlling Temper”- SHORT STORY Abhishek K Singh Taj Pharma

Abhishek kumar Singh Taj Pharma “Controlling Temper”- SHORT STORY

A STORY FROM ABHISHEK KUMAR SINGH,. CEO TAJ PHARMA INDIA (MUMBAI) There once was a little boy who had a bad temper. His father gave him a bag of nails and told him that every time he lost his temper, he must hammer a nail into the fence. The rst day the boy had driven 37 nails into the fence. Over the next few weeks as he learned to control his anger, the number of nails hammered daily, gradually dwindled down. He discovered it was easier to hold his temper than to drive those nails into the fence. Finally the day came when the boy didn’t lose his temper at all. He told his father about it and the father suggested that the boy now pull out one nail for each day that he was able to hold his temper. The days passed and the young boy was nally able to tell his father that all the nails were gone. The father took his son by the hand and led him to the fence. He said “you have done well, my son, but look at the holes in the fence. The fence will never be the same. When you say things in anger, they leave a scar just like this one.” Moral: You can put a knife in a man and draw it out. It won’t matter how many times you say I’m sorry, the wound is still there.

Make sure you control your temper the next time you are tempted to say something you will regret later.

“Controlling Temper”- SHORT STORY

[thoughtfulenthusiastgoatee-blog]

Abhishek Kumar Singh - Taj Pharma - EU regulator

EU regulator recommends approval of Taj Pharma's vaccines for European markets EMA's Committee for Medicinal Products for Human Use backed approval of the four vaccines for the European Markets to resolve vaccine shortages. End Quote (1888PressRelease) March 21, 2013 - Taj Pharma announced that the European Medicines Agency's Committee for Medicinal Products for Human Use backed approval of the four vaccines: 

Hepatitis-B (HepaVac®), DPT (Humogen®), Rabies (Rabivaxi®) and Meningococcal Polysaccharide (Neisseria meningitidis). The drugmaker indicated that the EMA's positive opinion was based on multi-centre trials involving more than 200 patients. Late-stage studies comparing licensed combination vaccines, including Serum Institute of India's vaccines, demonstrated that Taj Pharma's vaccines are safe and induces a robust immune response against all targeted diseases. The EMA noted that a pharmacovigilance plan will be implemented with these vaccines as part of its marketing authorisation. The company noted that these approvals will solve vaccine shortages and disease caused by the hepatitis B virus (HepaVac®), infectious diseases: diphtheria, pertussis (whooping cough), tetanus (Humogen®); rabies control (Rabivaxi®) and Neisseria meningitidis, a bacterium that causes meningitis (Meningococcal Polysaccharide). Taj Pharma noted that if approved, the vaccines will be used for the primary and booster vaccination. The product will be sold in Western Europe as stated brands by Taj Pharma BMS, a partnership with Bristol-Myers Squibb, and by the French company alone in Eastern European countries as Taj collaborated brands. Earlier this month, CEO of Taj Pharma Group Abhishek Kumar Singh said, "these vaccines which will be available in international markets under the Taj brand names, and are expected to be a "key growth driver" for the company this year." The drugmaker removed a previous vaccine, Hemavac, from the market in 2010 after the EMA identified decreased immunogenicity in the hepatitis B portion of the product. Merrill Lynch analyst MCLe Oerrigaud recently commented that "right now, Serum Institute of India has a monopoly in this area from India," with vaccines generating sales of 175 million pounds ($264 million) in 2012, EU approval is likely to dilute the monopoly in this specialist revenue stream. About EMA: The European Medicines Agency is a decentralised agency of the European Union, located in London. The Agency is responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union. HepaVac® Recombinant DNA Hepatitis-B Vaccine: Hepatitis B is a disease caused by the hepatitis B virus. The disease mainly affects the liver. However, if you are infected, the virus is present in body fluids such as blood, saliva, semen and vaginal fluid. In the UK it is estimated that about 1 person in 1,000 is infected with the hepatitis B virus. Humogen® DPT: (also DTP and DTwP) refers to a class of combination vaccines against three infectious diseases in humans: diphtheria, pertussis (whooping cough) and tetanus. The vaccine components include diphtheria and tetanus toxoids, and killed whole cells of the organism that causes pertussis (wP). Rabivaxi®: Rabies vaccine is a vaccine used to control rabies. Rabies can be prevented by vaccination, both in humans and other animals. Meningococcal Polysaccharide Vaccine: Meningococcal vaccine is a vaccine used against Neisseria meningitidis, a bacterium that causes meningitis, meningococcemia, septicemia, and rarely carditis, septic arthritis, or pneumonia. Routes: Intramuscular (conjugate), Subcutaneous (polysaccharide), Disease: Neisseria meningitidis. About Taj Pharmaceuticals Group (India): Taj Pharmaceuticals Limited is a pharmaceutical company founded and based in India. The company manufactures pharmaceutical formulations and API for India and other countries, owning about 450 brands and 4000 generic licenses. The company was established in 1995 as an enterprise and in 2004 became a public limited company. Responsibility Statement: Certain statements in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements that do not describe historical facts and statements that refer or relate to events or circumstances that the mentioned companies "estimates," "believes," or "expects" to happen or similar language. The forward-looking statements in this press release are based on the current expectations of the parties engaged and are made only as of the date of this press release and involve certain risks and uncertainties that could cause actual results to differ materially from future results that may be expressed or implied by such forward-looking statements. Unless required by law, no mentioned company undertake any obligations to update, change or revise any forward-looking statement, whether as a result of new information, additional or subsequent developments or otherwise.

[thoughtfulenthusiastgoatee-blog]

Abhishek Kumar Singh (Taj Pharma) Ceo

Abhishek Kumar Singh (Taj Pharma) By: workspace.co.uk/ 12th Sept 2014

In December 2006, Abhishek Singh launched the first 90 generics in the pharma isolated market of Lebanon. In its first year these cost effective generics received more than 1 million users who could not afford branded medicines in their own county. This new avenue of choice was built entirely by Abhishek Singh, 21-year-old with no previous extensive work expertise in pharmaceuticals industry. According to CNBC, Singh learned everything he needed to know through practical experience at pharma manufacturing units, and proposed to develop 4,000 generics in the next decade as a core goal. One interesting bit of news that really got my attention this week was that of Abhishek Singh, the 21-year-old millionaire (yes, millionaire at 21!), who sold his New Generics to much in need countries such as Lebanon, Brazil, Senegal for millions! It's quite an interesting story actually: Abhishek Singh started using the computer at 9, and began visiting his father pharma plants from 1999 when he was 11 – back when the concept of generic medicine was quite new in the market and India was known to only make copy products which are out of patent. Abhishek Singh's first 'success' was with Tacrolimus Capsules, an immunosuppressive drug used mainly after allogeneic "organ transplant" to lower the risk of organ rejection. This generic launch was as quite popular – so much so that this was tendered by almost 28 countries in a span of 4 years till the new bio-similar sirolimus Capsule. Abhishek Singh was offered $300,000 from a Turkey based venture capital funding billionaire for Tacrolimus; to sell its technology with full rights. He refused this money, along with the feedback and criticism that selling such right of a bio-similar which was already not affordable in India; would further mean deprivation access to such life saving medicines. The Globe and Mail from Canada ran a cool story on the 21 year old's rise in fame, as well as some unique advice offered to the young entrepreneur/ young millionaire. Worth a read! Abhishek Singh's who is satisfied with his company's current global exposure; highlights that it's very easy get investment in pharma company; however, if greedy investors are allowed on the board of noble pharma companies; the greed always leads to drug price manipulation and then even though a company may become large scale, but essential purpose and motto of A.K.Singh from Taj Pharma may be defeated; human kind shall not make money from/at the cost essential life saving medicines and access to medicine shall be basic human right.

Makes for a very interesting read!